These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16651645)

  • 1. Predicting vinorelbine disposition and toxicity: does BSA provide more than a "bad statistical association"?
    Baker SD; Sparreboom A
    J Clin Oncol; 2006 Jun; 24(16):2412-3. PubMed ID: 16651645
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.
    Wong M; Balleine RL; Blair EY; McLachlan AJ; Ackland SP; Garg MB; Evans S; Farlow D; Collins M; Rivory LP; Hoskins JM; Mann GJ; Clarke CL; Gurney H
    J Clin Oncol; 2006 Jun; 24(16):2448-55. PubMed ID: 16651648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.
    Schott AF; Rae JM; Griffith KA; Hayes DF; Sterns V; Baker LH
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):129-35. PubMed ID: 16283312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phlebitis after vinorelbine].
    Sauter C; Margulies A; Pestalozzi B
    Schweiz Med Wochenschr; 1998 Feb; 128(9):343. PubMed ID: 9544462
    [No Abstract]   [Full Text] [Related]  

  • 5. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.
    Rosner F
    Cancer; 1998 Sep; 83(5):1054-5. PubMed ID: 9731914
    [No Abstract]   [Full Text] [Related]  

  • 6. Dexamethasone as a probe for vinorelbine clearance.
    Puisset F; Dalenc F; Chatelut E; Cresteil T; Lochon I; Tisnes P; Roché H
    Br J Clin Pharmacol; 2005 Jul; 60(1):45-53. PubMed ID: 15963093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus intravenous vinorelbine: clinical safety profile.
    Gebbia V; Puozzo C
    Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer.
    Briasoulis E; Pappas P; Puozzo C; Tolis C; Fountzilas G; Dafni U; Marselos M; Pavlidis N
    Clin Cancer Res; 2009 Oct; 15(20):6454-61. PubMed ID: 19808873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.
    Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN; Yu QZ
    Respiration; 2008; 75(4):380-5. PubMed ID: 17851225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer.
    Deporte-Fety R; Simon N; Fumoleau P; Campone M; Kerbrat P; Bonneterre J; Fargeot P; Urien S
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):233-8. PubMed ID: 14634791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial.
    Gridelli C; Manegold C; Mali P; Reck M; Portalone L; Castelnau O; Stahel R; Betticher D; Pless M; Pons JT; Aubert D; Burillon JP; Parlier Y; De Marinis F
    Eur J Cancer; 2004 Nov; 40(16):2424-31. PubMed ID: 15519515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vinorelbine may not induce acute pain at the tumor site.
    Tralongo P; Di Mari A; Agueli R; Gebbia V
    J Pain Symptom Manage; 2006 Sep; 32(3):197-9. PubMed ID: 16939839
    [No Abstract]   [Full Text] [Related]  

  • 13. [The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study].
    Nakayama S; Matsubara N; Sakai T; Aso N
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):633-5. PubMed ID: 11977554
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
    Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of aging on chemotherapy.
    Malik SM
    Clin Lung Cancer; 2004 Jan; 5(4):243-4. PubMed ID: 14967077
    [No Abstract]   [Full Text] [Related]  

  • 17. Correspondence re: Cicchetti S, Jemec B, Gault DT: two case reports of vinorelbine extravasation: management and review of the literature. Tumori, 86: 289-292, 2000.
    Bertelli G; Garrone O; Bighin C; Dini D
    Tumori; 2001; 87(2):112-3. PubMed ID: 11401208
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC.
    Mencoboni M; Filiberti RA; Taveggia P; Del Corso L; Del Conte A; Covesnon MG; Puccetti C; Donati S; Auriati L; Amoroso D; Camerini A
    Anticancer Res; 2017 Jun; 37(6):3189-3194. PubMed ID: 28551663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced myelosuppression by vinorelbine: a comparison between different dose schedules by simulation.
    Urso R; Nencini C; Giorgi G; Fiaschi AI
    Eur Rev Med Pharmacol Sci; 2007; 11(6):413-7. PubMed ID: 18306910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can similar oral blood exposures between studies result in a different bioavailability?
    Puozzo C
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):838-41. PubMed ID: 16557414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.